Dyadic Logo Current.jpg
Dyadic Reports 2023 Full Year Results and Recent Company Progress
March 28, 2024 16:00 ET | Dyadic International, Inc.
Closed a $6.0 million convertible note in a private placement, with a conversion price of $1.79 and no warrantsReported positive topline data from First-In-Human Phase 1 trial demonstrated clinical...
Dyadic Logo Current.jpg
Dyadic Announces Change in Board and Management Leadership Roles
March 28, 2024 08:30 ET | Dyadic International, Inc.
JUPITER, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient...
Global Insulin Storage Devices Market
Global Insulin Storage Devices Market to Reach USD 1524.61 Million by 2028 at a CAGR of 8.71%
March 27, 2024 10:42 ET | Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Global Insulin Storage Devices Market (2023-2028) Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession,...
Global Smart Insulin Pens Market
Global Smart Insulin Pens Market Report 2024, Featuring Profiles of Companion Medical, Emperra, Eli Lilly, Bigfoot Biomedical, Diamesco, Pendiq, Medtronic, Diabnext, Diabecare and Capillary Biomedical
March 25, 2024 12:13 ET | Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Global Smart Insulin Pens Market" report has been added to ResearchAndMarkets.com's offering.The global smart insulin pens market accounted for USD...
Dyadic Logo Current.jpg
CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
March 11, 2024 09:57 ET | Dyadic International, Inc.
In a release issued under the same headline on Monday, March 11th by Dyadic International, Inc. (NASDAQ: DYAI), please note that the city in the dateline should be JUPITER, Fla. not JUNIPER, Fla. The...
Dyadic Logo Current.jpg
Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
March 11, 2024 08:30 ET | Dyadic International, Inc.
JUNIPER, Fla., March 11, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Global Emerging Insulin Drug and Delivery Technologies Market
Global Emerging Insulin Drug and Delivery Technologies Market Analysis: Smart Pens Unveiled as Fastest-Growing Segment, Predicted to Register CAGR of 12.6% During 2023-2028
March 08, 2024 04:15 ET | Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global Insulin Pen Market Report 2024: Data from 2020-2022, Estimates for 2023 and Compound Annual Growth Rates Projections through 2028
February 22, 2024 11:17 ET | Research and Markets
Dublin, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Insulin Pen Market" report has been added to ResearchAndMarkets.com's offering. The global insulin pen market was valued at $9.9 billion in...
22157.jpg
Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033, Featuring Novo Nordisk, Eli Lilly and Sanofi
February 14, 2024 11:59 ET | Research and Markets
Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The "Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033" report has been added to ResearchAndMarkets.com's...
22157.jpg
North America Sulfonylureas Market Projected to Grow, Hitting USD 3.35 Billion Valuation by 2028 with Notable CAGR of 1.90%
January 30, 2024 20:00 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "North America Sulfonylureas Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ...